Parathyroid disorders often remain underdiagnosed due to subtle or non-specific symptoms, especially in early stages. This creates a significant opportunity for companies to develop and promote advanced screening tools and awareness programs. Increasing routine health check-ups and incorporating parathyroid hormone (PTH) testing into standard diagnostic panels can help identify a broader patient pool, thereby driving market growth. Technological innovation in diagnostic procedures is significantly enhancing the detection and management of parathyroid disorders. Advanced imaging techniques such as high-resolution ultrasound, sestamibi scans, and 4D computed tomography (CT) are improving localization and diagnosis accuracy. In addition, the development of sensitive biochemical assays for calcium and parathyroid hormone (PTH) levels allows for early and precise detection. These advancements enable timely treatment, which in turn drives the demand for diagnostic services and associated healthcare solutions. Read More - https://www.theinsightpartners.com/reports/parathyroid-disorders-market